Citations

Showing 10 of 108152 citations.

Asthma and anaphylaxis
Tanno, Luciana Kase , Olivieri, Bianca , Caminati, Marco , Gonzalez‐Estrada, Alexei

Mayo Clinic

Current Opinion in Allergy & Clinical Immunology | June 28, 2019 | Volume: 19 | Issue: 5 | Pages: 447-455

10.1097/aci.0000000000000566 | PMID 31261185 Get It

Purpose of review Both asthma and anaphylaxis are recognized noncommunicable hypersensitivity conditions, which should be correctly diagnosed and treated/controlled in order to decrease avoidable deaths. Nevertheless, their association is not completely clear. We here propose to review the current and new evidence-based data of asthma and anaphylaxis in the view of the new knowledge in the field that can support the quality practice and empower allergists and health professionals in treating symptoms and preventing death. Recent findings Hypersensitivity life-threatening conditions, such as anaphylaxis and asthma can coexist, mimic or worse each other. Asthma itself is not a strong predictor of more severe anaphylaxis. However, poor asthma control associated with more severe anaphylaxis reactions in all ages. In children, asthma is associated with the severity and recurrences of anaphylactic reactions. Summary Although recent data point for the association between asthma and anaphylaxis, we still do not have harmonized evidence to confirm if we are dealing with two independent comorbidities one worsening each other. However, as far as this review is covering two relevant public health problems in the field of allergy, it is mandatory put in place decisions supporting recommendations to better manage the affected patients and reduce the risk. General strategies should include regular notification of this association, optimization of the classification and coding for anaphylaxis and asthma (new ICD 11 allergy codes) in order to harmonize epidemiological stratified data, early diagnosis of asthma in childhood, regular investigation of asthma in cases of anaphylaxis and optimization of the asthma control and lung function for all patients with indication to provocation tests, desensitization or allergen immunotherapy regardless to the trigger. Implementation of these strategies will involve national and international support for ongoing efforts in relationship with networks of centres of excellence to provide personalized management for the most at-risk patients and prevent death.
Central Nervous System Infections Due to Coccidioidomycosis
Jackson, Niki, Blair, Janis E. , Ampel, Neil M. , Jackson, Niki R

Mayo Clinic

Journal of Fungi | June 28, 2019 | Volume: 5 | Issue: 3 | Pages: 54

10.3390/jof5030054 | PMID 31261704 Get It

Coccidioidomycosis is a common infection in the western and southwestern United States as well as parts of Mexico and Central and South America and is due to the soil-dwelling fungi Coccidioides. Central nervous system (CNS) infection is an uncommon manifestation that is nearly always fatal if untreated. The presentation is subtle, commonly with headache and decreased mentation. The diagnosis should be considered in patients with these symptoms in association with a positive serum coccidioidal antibody test. The diagnosis can only be established by analysis of cerebrospinal fluid (CSF), which typically demonstrates a lymphocytic pleocytosis, hypoglycorrhachia, elevated protein, and positive CSF coccidioidal antibody. Cultures are infrequently positive but a proprietary coccidioidal antigen test has reasonable sensitivity. Current therapy usually begins with fluconazole at 800 mg daily but other triazole antifungals also have efficacy and are often used if fluconazole fails. Triazole therapy should be lifelong. Intrathecal amphotericin B, the original treatment, is now reserved for those in whom triazoles have failed. There are several distinct complications of CNS coccidioidal infection, the most common of which is hydrocephalus. This is nearly always communicating and requires mechanical shunting in addition to antifungal therapy. Other complications include cerebral vasculitis, brain abscess, and arachnoiditis. Management of these is difficult and not well established.
Brainstem Diffuse Axonal Injury and Consciousness
Sandhu, Sukhwinder J.S. , Fiester, Peter , Natter, Patrick , Tavanaiepour, Daryoush , Rahmathulla, Gazanfar , Rao, Dinesh , Sandhu, Sukhwinder, Sandhu, Sukhwinder S , Soule, Erik

Mayo Clinic

Journal of Clinical Imaging Science | June 28, 2019 | Volume: 9 | Issue: No issue available | Pages: 32

10.25259/jcis-11-2019 | PMID 31508267 Get It

Background: Severe traumatic brain injuries (TBI), commonly due to motor vehicle accidents may cause death and long-term disability especially when the acceleration-deceleration force on the brain is massive. This may cause shearing of the axonal connections within the cerebral cortex and brainstem in a process referred to as diffuse axonal injury (DAI). Extensive DAI has been postulated to be a poor prognostic indicator for neurological recovery. In our institution, several patients with Grade 3 DAI were observed to recover and achieve neurological outcomes greater than expected given the presence of brainstem injury. Methods: MRI studies from 100 patients admitted to a large tertiary trauma center for TBI were retrospectively analyzed by two fellowship-trained neuroradiologists. The size of DAI lesions, location of injury within the brainstem, and the number of discrete DAI lesions were measured and recorded. Glasgow Coma Scale (GCS) on arrival and at discharge was noted, as well as the presence of other neurological injuries. Results: Of 20 patients initially noted to have DAI with lesions of the brainstem, eight of them were discharged with Glasgow Coma Scale (GCS) of 14–15. The 12 patients discharged with reduced consciousness (average GC 7.1) demonstrated a greater number of larger lesions, with a predilection for the dorsal pons. Conclusion: These results suggest that large, numerous pontine lesions may indicate worse neurological outcomes in patients with these findings.
Characteristics of long‐term survivors with multiple myeloma: A National Cancer Data Base analysis
Hsieh, Ronan W. , Abeykoon, Jithma P. , Kapoor, Prashant , Kumar, Shaji , Kourelis, Taxiarchis , Warsame, Rahma , Lacy, Martha Q. , Kyle, Robert A. , Kumar, Shaji K , Kourelis, Taxiarchis V, Warsame, Rahma M, Go, Ronald S. , Gertz, Morie A. , Buadi, Francis K. , Leung, Nelson , Gonsalves, Wilson I. , Dispenzieri, Angela , Rajkumar, S. Vincent , Paludo, Jonas

Mayo Clinic

Cancer | June 28, 2019 | Volume: 125 | Issue: 20 | Pages: 3574-3581

10.1002/cncr.32357 | PMID 31251390 Get It

BackgroundThere exist insufficient data characterizing patients with multiple myeloma (MM) who experienced prolonged survival. A population‐based analysis of long‐term survivors was conducted to investigate the roles of sociodemographic factors and upfront stem cell transplantation (SCT).MethodsThe National Cancer Data Base is a US cancer database of approximately 34 million patients from >1500 cancer centers. Patients with MM were identified using the International Classification of Diseases for Oncology (ICD‐O) code 9732 from January 2004 to December 2006 and were divided into 4 groups based on overall survival (OS). Sociodemographic characteristics, treatment facility, and use of SCT were recorded. The univariate and multivariate analyses were performed using multiple logistic regression and Pearson chi‐square tests.ResultsA total of 26,986 patients with MM were identified. The median OS was 2.74 years. The majority of patients were male (54%), white (77%), insured (93%) and otherwise healthy (78%), lived in a metropolitan area (82%), were of high income (66%) and educational (58%) levels, and received treatment at nonacademic facilities (63%). Upfront SCT was used in 10% of patients. One in 6 patients (16%) were long‐term survivors (group 4). When comparing group 4 (OS of ≥8.22 years) with the other groups (OS of <8.22 years), young age, female sex, high income and educational levels, residence in a rural area, insured status, no comorbidity, receipt of upfront SCT, and treatment at high‐volume facilities were associated with long‐term survival.ConclusionsKey differences in sociodemographic characteristics, patient volume at treatment facilities, and upfront SCT were associated with long‐term survival. Improvements in health care access and health literacy, upfront SCT, and treatment at high‐volume facilities might prolong patient survival.
Extensor Mechanism Reconstruction with Use of Marlex Mesh
Abdel, Matthew P. , Pagnano, Mark W. , Perry, Kevin I. , Hanssen, Arlen D. , Abdel, Matthew P

Mayo Clinic

JBJS Essential Surgical Techniques | June 28, 2019 | Volume: 9 | Issue: 2 | Pages: e21

10.2106/jbjs.st.18.00106 | PMID 31579539 Get It

Background: Marlex mesh reconstruction of the extensor mechanism via a stepwise surgical approach is a viable option to treat disruption of the extensor mechanism after total knee arthroplasty (TKA). Description: Extensor mechanism reconstruction with mesh involves a stepwise surgical approach with a particular monofilament polypropylene mesh (Marlex; C.R. Bard). Prior to incision, the 10 × 14-in (25 × 36-cm) sheet of Marlex mesh is rolled onto itself 8 to 10 times and sewn together. If the tibia is not being revised, a burr is utilized to create a trough in the tibia. Five centimeters of the tapered portion of the mesh are predipped in bone cement. The remaining cement is inserted into the trough. The tapered portion of the mesh is inserted into the tibial trough, ensuring that the mesh is fully seated. After the cement has cured, a lag screw is placed across the mesh and cement and into host bone. If the tibia is being revised at the time of the Marlex mesh reconstruction, the 5 cm of predipped mesh is placed anteriorly in the medullary canal in line with the tibial crest. The remaining procedure is similar regardless of whether the components are revised. At the level of the joint, it is essential to ensure that the mesh is covered with host tissue. Next, the proximal reconstruction, which involves mobilizing the vastus lateralis and vastus medialis obliquus (VMO) distally by releasing all ventral and dorsal soft-tissue adhesions off the muscle bellies, is completed. Finally, the mesh is unitized to the vastus lateralis. With the limb maintained in full extension, the mesh is pulled directly proximally while another assistant pulls the vastus lateralis distally and medially. The vastus lateralis is deep, and the mesh is directly on top of it. Multiple nonabsorbable sutures are placed through the mesh and vastus lateralis. The VMO is then pulled distally and laterally over the mesh (which is now unitized to the vastus lateralis) by an assistant. Multiple nonabsorbable sutures (usually 8) are placed through the VMO, through the mesh, and through the vastus lateralis, unitizing the entire construct. Alternatives: Nonoperative treatments include a drop-lock hinge brace or knee immobilizer. Operative treatments include whole extensor mechanism allograft reconstruction or Achilles tendon allograft reconstruction. Rationale: The procedure avoids the limitations of allograft with regard to availability, cost, and risk of disease transmission. The technique is reproducible and cost-effective, and it has excellent functional and survivorship outcomes.
Enablers and Barriers to Implementing ICU Follow-Up Clinics and Peer Support Groups Following Critical Illness: The Thrive Collaboratives*
McPeake, Joanne , Hibbert, Elizabeth , Boehm, Leanne M. , Aparanji, Krishna, Bakhru, Rita N. , Bastin, Anthony J. , Beesley, Sarah J. , Beveridge, Lynne , Butcher, Brad W. , Drumright, Kelly, Eaton, Tammy L. , Firshman, Penelope , Fritschle, Andrew, Hope, Aluko A. , Johnson, Annie, Kenes, Michael T. , Khan, Babar , Kloos, Janet A. , Kross, Erin K. , MacTavish, Pamela , Meyer, Joel , Montgomery-Yates, Ashley , Quasim, Tara , Saft, Howard L., Slack, Andrew, Stollings, Joanna L. , Weinhouse, Gerald L., Whitten, Jessica, Netzer, Giora, Hopkins, Ramona O., Iwashyna, Theodore J. , Sevin, Carla M. , Haines, Kimberley , Farley, Thomas, Holdsworth, Clare, Mikkelsen, Mark E.

Mayo Clinic

Critical Care Medicine | June 28, 2019 | Volume: 47 | Issue: 9 | Pages: 1194-1200

10.1097/ccm.0000000000003818 | PMID 31241499 Get It

Objectives: Data are lacking regarding implementation of novel strategies such as follow-up clinics and peer support groups, to reduce the burden of postintensive care syndrome. We sought to discover enablers that helped hospital-based clinicians establish post-ICU clinics and peer support programs, and identify barriers that challenged them. Design: Qualitative inquiry. The Consolidated Framework for Implementation Research was used to organize and analyze data. Setting: Two learning collaboratives (ICU follow-up clinics and peer support groups), representing 21 sites, across three continents. Subjects: Clinicians from 21 sites. Measurement and Main Results: Ten enablers and nine barriers to implementation of “ICU follow-up clinics” were described. A key enabler to generate support for clinics was providing insight into the human experience of survivorship, to obtain interest from hospital administrators. Significant barriers included patient and family lack of access to clinics and clinic funding. Nine enablers and five barriers to the implementation of “peer support groups” were identified. Key enablers included developing infrastructure to support successful operationalization of this complex intervention, flexibility about when peer support should be offered, belonging to the international learning collaborative. Significant barriers related to limited attendance by patients and families due to challenges in creating awareness, and uncertainty about who might be appropriate to attend and target in advertising. Conclusions: Several enablers and barriers to implementing ICU follow-up clinics and peer support groups should be taken into account and leveraged to improve ICU recovery. Among the most important enablers are motivated clinician leaders who persist to find a path forward despite obstacles.
Metabolic Syndrome Induces Release of Smaller Extracellular Vesicles from Porcine Mesenchymal Stem Cells
Conley, Sabena M., Shook, John E., Zhu, Xiang-Yang, Eirin, Alfonso , Jordan, Kyra L., Woollard, John R. , Isik, Busra , Hickson, LaTonya J. , Puranik, Amrutesh S. , Lerman, Lilach O. , Hickson, LaTonya J , Eirin, Alfonso , Puranik, Amrutesh S , Shook, John E.

Mayo Clinic

Cell Transplantation | June 28, 2019 | Volume: 28 | Issue: 9-10 | Pages: 1271-1278

10.1177/0963689719860840 | PMID 31250656 Get It

Mesenchymal stromal/stem cells (MSCs) belong to the endogenous cellular reparative system, and can be used exogenously in cell-based therapy. MSCs release extracellular vesicles (EVs), including exosomes and microvesicles, which mediate some of their therapeutic activity through intercellular communication. We have previously demonstrated that metabolic syndrome (MetS) modifies the cargo packed within swine EV, but whether it influences their phenotypical characteristics remains unclear. This study tested the hypothesis that MetS shifts the size distribution of MSC-derived EVs. Adipose tissue-derived MSC-EV subpopulations from Lean ( n = 6) and MetS ( n = 6) pigs were characterized for number and size using nanoparticle-tracking analysis, flow cytometry, and transmission electron microscopy. Expression of exosomal genes was determined using next-generation RNA-sequencing (RNA-seq). The number of EV released from Lean and MetS pig MSCs was similar, yet MetS-MSCs yielded a higher proportion of small-size EVs (202.4 ± 17.7 nm vs. 280.3 ± 15.1 nm), consistent with exosomes. RNA-seq showed that their EVs were enriched with exosomal markers. Lysosomal activity remained unaltered in MetS-MSCs. Therefore, MetS alters the size distribution of MSC-derived EVs in favor of exosome release. These observations may reflect MSC injury and membrane recycling in MetS or increased expulsion of waste products, and may have important implications for development of adequate cell-based treatments.
Babesiosis: A Retrospective Review of 38 Cases in the Upper Midwest
O’Horo, John C. , Fida, Madiha , O'horo, John, Abu Saleh, Omar , O'Horo, John C , Fida, Madiha

Mayo Clinic

Open Forum Infectious Diseases | June 28, 2019 | Volume: 6 | Issue: 7 | Pages: No page available

10.1093/ofid/ofz311 | PMID 31363764 Get It

Abstract Babesiosis is an emerging health risk, and clinicians need to be aware of its different clinical manifestations. In our cohort of 38 patients, almost half did not recall a tick bite, and diagnosis was delayed due to the nonspecific nature of symptoms. Sixty-eight percent of patients required hospitalization, with 21% requiring intensive care unit stay. Coinfection with Lyme, anaplasma, or both Lyme and anaplasma was seen in 24%, 5%, and 8% of the patients, respectively. None of the patients in our cohort died from their disease.
Letter: Management of a Previously Coiled Anterior Cerebral Artery Aneurysm in a Child: 3-Dimensional Operative Video
Patra, Devi Prasad, Krishna, Chandan , Turkmani, Ali , Abi-Aad, Karl R., Welz, Matthew E., Patra, Devi P. , Bendok, Bernard R.

Mayo Clinic

Operative Neurosurgery | June 28, 2019 | Volume: 17 | Issue: 2 | Pages: E93-E94

10.1093/ons/opz144 | PMID 31250906 Get It

More II It than Meets the Eye: Outcomes After Single-Fraction Stereotactic Radiosurgery in a Case Series of Low-Grade Arteriovenous Malformations
Graffeo, Christopher S. , Link, Michael J. , Stafford, Scott L., Garces, Yolanda I. , Foote, Robert L. , Pollock, Bruce E.

Mayo Clinic

Operative Neurosurgery | June 28, 2019 | Volume: 18 | Issue: 2 | Pages: 136-144

10.1093/ons/opz153 | PMID 31250901 Get It

Abstract BACKGROUND Surgical resection is typically cited as the optimal treatment of patients with Spetzler-Martin Grade I-II arteriovenous malformation (AVM). OBJECTIVE To report our experience with single-fraction stereotactic radiosurgery (SRS) for Spetzler-Martin Grade I-II AVM. METHODS A prospectively maintained registry was reviewed for patients with nonsyndromic Spetzler-Martin Grade I-II AVM having SRS from 1990 to 2011. Patients with <24 mo of follow-up or prior radiotherapy/SRS were excluded, resulting in a study population of 173 patients. Actuarial analysis was performed using the Kaplan-Meier method, and Cox proportional hazards modeling was performed with excellent outcomes (obliteration without new deficits) as the dependent variable. RESULTS Median post-SRS follow-up was 68 mo (range, 24-275). AVM obliteration was achieved in 132 (76%) after initial SRS. Eleven additional patients achieved obliteration after repeat SRS for an overall obliteration rate of 83%. The rate of obliteration was 60% at 4 yr and 78% at 8 yr. Post-SRS hemorrhage occurred in 7 patients (4%), resulting in 3 minor deficits (2%) and 1 death (<1%). Radiation-induced complications occurred in 5 patients (3%), resulting in minor deficits only. One hundred and thirty-seven patients (79%) had excellent outcomes at last follow-up. CONCLUSION SRS is a safe and effective treatment for patients with Spetzler-Martin Grade I-II AVM. Selection bias is likely a contributing factor to explain the superior outcomes generally noted in reported series of microsurgery for patients with low grade AVM.